Groupe la Francaise’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.3M Sell
113,485
-5,744
-5% -$3.12M 0.76% 28
2025
Q4
$68.6M Sell
119,229
-1,760
-1% -$995K 0.96% 25
2025
Q3
$57.8M Buy
120,989
+43,964
+57% +$20.5M 0.78% 30
2025
Q2
$31.5M Buy
77,025
+13,232
+21% +$5.53M 0.51% 39
2025
Q1
$32.2M Sell
63,793
-1,595
-2% -$864K 0.68% 39
2024
Q4
$33.3M Buy
+65,388
New +$36M 0.82% 28

Other funds holding TMO

Groupe la Francaise's TMO Position: Q1 2026 in Review

Groupe la Francaise reduced its Thermo Fisher Scientific (TMO) stake by 4.8% in Q1 2026, selling an estimated $3.12M and leaving 113,485 shares worth $55.3M. The position accounts for 0.76% of the portfolio, ranked #28.

Groupe la Francaise first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $68.6M in Q4 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Groupe la Francaise held 113,485 shares of Thermo Fisher Scientific worth $55.3M as of Q1 2026.
  • Groupe la Francaise sold 5,744 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.12M.
  • Thermo Fisher Scientific made up 0.76% of Groupe la Francaise's portfolio in Q1 2026, its #28 holding.
  • Groupe la Francaise first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Groupe la Francaise's Thermo Fisher Scientific position peaked at $68.6M in Q4 2025.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.